Cytotoxic agents comprising maytansinoids and their therapeutic use

• US 5,416,064 A
• Filed: 12/07/1992
• Issued: 05/16/1995
• Est. Priority Date: 10/25/1989
• Status: Expired due to Term

• Current Assignee: ImmunoGen Incorporated
• Original Assignee: ImmunoGen Incorporated
• Inventors: Chari, Ravi J., Blattler, Walter A., Lambert, John M., Goldmacher, Victor S.
• Primary Examiner(s): Mars, Howard T.
• Assistant Examiner(s): Hydorn, Michael B.
• Application Number:
  US07/986,578
• Time in Patent Office: 890 Days
• Field of Search: 540/462, 514/229.5
• US Class Current: 514/229.5
• CPC Class Codes: A61K 31/535 having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
• CPC Class Codes: A61K 47/6803 Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
• CPC Class Codes: Y02A 50/30 Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

A cytotoxic agent comprising one or more maytansinoids linked to a cell binding agent. A therapeutic agent for killing selected cell populations comprising: (a) a cytotoxic amount of one or more maytansinoids linked to a cell binding agent, and (b) a pharmaceutically acceptable carrier, diluent or excipient. A method for killing selected cell populations comprising contacting a cell population or tissue suspected of containing cells from said selected cell population with a cytotoxic amount of a cytotoxic agent comprising one or more maytansinoids linked to a cell binding agent. An N-methyl-alanine-containing ester of maytansinol or an analogue of maytansinol, said N-methyl-alanine-containing ester comprising a linking group capable of linking an N-methyl-alanine-containing maytansinoid ester to a chemical moiety. N-methyl-cysteine-containing ester of maytansinol or an analogue of maytansinol.

Claims

1. A cytotoxic agent comprising one or more maytansinoids linked to a hormone or growth factor via a linking group comprising a disulfide group.

2. The cytotoxic agent of claim 1, wherein the maytansinoid is a maytansinoid ester.

3. The cytotoxic agent of claim 2, wherein the maytansinoid ester is a C-3 maytansinoid ester.

4. The cytotoxic agent of claim 3, wherein the maytansinoid ester is an N-methyl-alanine-containing maytansinoid ester.

5. The cytotoxic agent of claim 4, wherein the N-methyl-alanine-containing maytansinoid ester is represented by formula (I):

##STR7## wherein;

l represents an integer of 1 to 10; and

may represents a maytansinoid.

6. The cytotoxic agent of claim 4, wherein the N-methyl-alanine-containing maytansinoid ester is represented by formula (II):

##STR8## wherein;

R₁ and R₂, which may be the same or different, represents H, CH₃ or CH₂ CH₃ ;

m represents 0, 1, 2 or 3; and

may represents a maytansinoid.

7. A cytotoxic agent of claim 4, wherein the N-methyl-alanine-containing maytansinoid ester is represented by formula (III):

##STR9## wherein;

n represents an integer of 3 to 8; and

may represents a maytansinoid.

8. The cytotoxic agent of claim 4, wherein the N-methyl-alanine-containing maytansinoid ester is a C-3 ester of maytansinol.

9. The cytotoxic agent of claim 8, wherein the maytansinoid ester is an ester of dechloro maytansinol.

10. The cytotoxic agent of claim 8, wherein the C-3 ester of maytansinol is represented by formula (IV):

##STR10## wherein;

l represents 1, 2 or 3;

Y₀ represents Cl or H; and

X₃ represents H or CH₃.

11. The cytotoxic agent of claim 8, which comprises N-methyl-N-(3-methyldithiopropanoyl)-L-alanine.

12. The cytotoxic agent of claim 3, wherein the maytansinoid ester is an N-methyl-cysteine-containing maytansinoid ester.

13. The cytotoxic agent of claim 12, wherein the N-methyl-cysteine-containing maytansinoid ester is represented by formula (V):

##STR11## wherein;

o represents 1, 2 or 3;

p represents O or an integer of 1 to 10; and

may represents a maytansinoid.

14. The cytotoxic agent of claim 12, wherein the N-methyl-cysteine-containing ester is a C-3 ester of maytansinol.

15. The cytotoxic agent of claim 14, wherein the maytansinoid ester is an ester of dechloro maytansinol.

16. The cytotoxic agent of claim 12, wherein the N-methyl-cysteine-containing maytansinoid ester is represented by formula (VI):

##STR12## wherein;

o represents 1, 2, or 3;

q represents O or an integer of 1 to 10;

Y₀ represents Cl or H; and

X₃ represents H or CH₃.

17. The cytotoxic agent of claim 1, wherein said hormone is melanocyte stimulating hormone (MSH) or an analogue thereof.

18. The cytotoxic agent of claim 1, wherein said hormone is thyroid stimulating hormone (TSH) or an analogue thereof.

19. The cytotoxic agent of claim 1, wherein said growth factor is epidermal growth factor (EGF).

20. The cytotoxic agent of claim 1, wherein said growth factor is transforming growth factor alpha (TGF-α

).